Jim Cramer - Mad Money Insmed INSM-Q DON'T BUY Jul 09, 2025

Too speculative. They lose money.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$96.470

Stock price when the opinion was issued

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

Tony Ciero, CFA and CFP

Caldwell Securities

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Thom - CIM, DMS, FCSI

Moat Financial

Mike Philbrick

ReSolve Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money Insmed INSM-Q DON'T BUY Jul 09, 2025

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals